SOURCE: Equity News Circuit

Equity News Circuit

May 28, 2013 08:20 ET

Free Research Reports on FCEL, TNP, VNDA and ZIOP Issued by the Paragon Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit

NEW YORK, NY--(Marketwired - May 28, 2013) - The Paragon Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Paragon is an essential resource for hundreds of thousands of investors across the country.

FuelCell Energy, Inc. (NASDAQ: FCEL) shares soared 28.81 percent on volume of 16.39 million shares traded Friday. The stock traded in a range of $1.16 to $1.53 before settling to close at $1.52 a share. FuelCell Energy is scheduled to releases results for the second quarter of 2013 after market close on Wednesday, June 5th.

Find out more about FuelCell Energy including full access to the free equity report at: www.ParagonReport.com/FCEL

Tsakos Energy Navigation Ltd. (NYSE: TNP) shares spiked 18.10 percent on volume of 2.45 million shares traded Friday to close at $4.96. The company reported a net income of $1.0 million for the first quarter of 2013, a significant improvement from the net loss of $8.8 million posted in the year ago quarter.

Find out more about Tsakos Energy Navigation including full access to the free equity report at: www.ParagonReport.com/TNP

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) shares gained 17.70 percent on volume of 2.59 million shares traded Friday. The stock traded in the range of $7.11 to $8.75 before settling to close at $8.38. The company has recently been named the 2013 Life Science Firm of the Year by the Tech Council of Maryland.

Find out more about Vanda Pharmaceuticals including full access to the free equity report at: www.ParagonReport.com/VNDA

ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) shares surged 29.75 percent on volume of 16.77 million shares traded Friday. The stock traded in a range of $2.08 to $2.96 before settling to close at $2.62 a share. ZIOPHARM is scheduled to present at the 38th Annual Deutsche Bank Health Care Conference on May 29th.

Find out more about ZIOPHARM Oncology including full access to the free equity report at: www.ParagonReport.com/ZIOP

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information